mediabest science Health officials said an investigation by BioNTech found no safety issues in the batch with packaging defects for some vials, as well as in a separate, unused batch of the vaccine.

Hong Kong will resume administering the coronavirus vaccine developed by Pfizer and BioNTech on Monday following a 12-day suspension over packaging defects detected in one batch, officials said.…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.